These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 380492

  • 1. Effects of dopamine agonists and antagonists in Tourette's disease.
    Feinberg M, Carroll BJ.
    Arch Gen Psychiatry; 1979 Aug; 36(9):979-85. PubMed ID: 380492
    [Abstract] [Full Text] [Related]

  • 2. Gilles de la Tourette's disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient.
    Meyerhoff JL, Snyder SH.
    Psychopharmacologia; 1973 Aug; 29(3):211-20. PubMed ID: 4512896
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.
    Ross MS, Moldofsky H.
    Am J Psychiatry; 1978 May; 135(5):585-7. PubMed ID: 347954
    [Abstract] [Full Text] [Related]

  • 5. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G, Thornburg JE, Moore KE.
    Psychopharmacology (Berl); 1976 Nov 24; 50(3):225-9. PubMed ID: 826966
    [Abstract] [Full Text] [Related]

  • 6. Gilles de la Tourette's syndrome following methylphenidate administration.
    Golden GS.
    Dev Med Child Neurol; 1974 Feb 24; 16(1):76-8. PubMed ID: 4521612
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dopamine autoreceptor stimulation: clinical significance.
    Meltzer HY.
    Pharmacol Biochem Behav; 1982 Feb 24; 17 Suppl 1():1-10. PubMed ID: 6223322
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol.
    Caine ED, Ludlow CL, Polinsky RJ, Ebert MH.
    J Am Acad Child Psychiatry; 1984 Mar 24; 23(2):147-52. PubMed ID: 6585416
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB.
    Res Publ Assoc Res Nerv Ment Dis; 1976 Mar 24; 55():459-65. PubMed ID: 1070064
    [Abstract] [Full Text] [Related]

  • 13. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C, Fibiger HC, Phillips AG.
    Brain Res; 1982 Dec 16; 253(1-2):185-93. PubMed ID: 6817850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparative study of the locomotor activity effects of apomorphine and the "atypical dopamine agonists" (piribedil and S3608).
    Offermeier J, van Rooyen JM.
    Life Sci; 1986 Mar 10; 38(10):895-903. PubMed ID: 3081774
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics.
    Shapiro AK, Shapiro E, Eisenkraft GJ.
    Arch Gen Psychiatry; 1983 Nov 10; 40(11):1235-40. PubMed ID: 6139100
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.
    Butterworth RF, Gonce M, Barbeau A.
    Can J Neurol Sci; 1977 Nov 10; 4(4):285-8. PubMed ID: 145893
    [Abstract] [Full Text] [Related]

  • 20. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M, Kurkulos ME, Silva L.
    Pharmacol Biochem Behav; 1982 Dec 10; 17(6):1305-8. PubMed ID: 6891794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.